Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Intellia Therapeutics Inc.
Sponsor

Intellia Therapeutics Inc.

United States 40 Erie Street, 02139-4254, United States

About the sponsor

Clinical research includes hereditary angioedema, with studies focused on hereditary angioedema due to C1 esterase inhibitor deficiency and related attack prevention. The programme also includes long-term follow-up in treated participants and evaluation of disease control in adults with recurrent swelling episodes.

  • HAE attacks
  • C1 esterase inhibitor deficiency
  • Long-term safety

Research activity in this area is centred on reducing disease burden in patients with recurrent angioedema episodes.

About Specializations

Intellia Therapeutics Inc. runs clinical trials in conditions such as Hereditary angioedema, Hereditary neuropathic amyloidosis, Cardiac amyloidosis, Emphysema, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Cardiac amyloidosis+1

Recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ziclumeran
  • Sponsor:Intellia Therapeutics Inc.

Study of NTLA-2001 for Patients with Transthyretin Amyloidosis and Heart Disease

Recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Intellia Therapeutics Inc.

Hereditary angioedema

Recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lonvoguran
  • Sponsor:Intellia Therapeutics Inc.

Hereditary angioedema

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lonvoguran
  • Sponsor:Intellia Therapeutics Inc.

Hereditary neuropathic amyloidosis

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ziclumeran
  • Sponsor:Intellia Therapeutics Inc.

Emphysema

Not recruiting
InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Messenger Rna Encoding Cas9
  • Sponsor:Intellia Therapeutics Inc.

Hereditary angioedema

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lonvoguran
  • Sponsor:Intellia Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.